The Impact of a Dietitian in the Implementation of Nutrition Recommendations During Intensive Care

NCT ID: NCT01749488

Last Updated: 2016-08-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2015-10-31

Study Completion Date

2018-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of this study is to evaluate the impact of the intervention of a dietician on the energy balance accumulated over seven days of intensive care.

Energy balance is defined as the difference between the target recommended energy and total calorie intake actually received.

This is a randomized-cluster study; participating centers are randomized into experimental and control groups.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The secondary objectives of this study are to compare the impact of the intervention of a dietician on:

* daily and accumulated energy balance at the end of the intensive care unit (ICU) stay
* deficits in protein intake per day, accumulated over 7 days, and accumulated for the ICU stay
* intake of vitamins, trace elements and pharmaco-nutrients per day
* predominant route of nutrition administration (enteral / parenteral / mixed)
* the course of the stay: duration of mechanical ventilation, organ failure, the ICU stay, number of days on antibiotics
* the presence / absence of complications: mortality, on catheter bacteremia, ventilator acquired pneumonia, other infections, bedsores, episodes of hyper-or hypoglycemia
* presence/absence of diarrhea
* costs related to the management of malnourished patients in terms of enteral and parenteral nutritional therapy, dietary supplements, antibiotics and sedatives as well as the costs of ICU stay and those related to diarrhea and sores

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intensive Care

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control intensive care wards

This is a randomized cluster trial. The centers randomized into this arm will serve as controls. No interventions will be implemented for these centers.

Group Type NO_INTERVENTION

No interventions assigned to this group

Experimental intensive care wards

This is a randomized cluster trial. The centers randomized into this arm will designate a dietitian who will help the ward implement current recommendations for the nutrition of patients undergoing intensive care.

Intervention: Designated dietitian for the ward

Group Type EXPERIMENTAL

Designated dietitian for the ward

Intervention Type OTHER

This is a randomized cluster trial. The centers randomized into this arm will designate a dietitian who will help the ward implement current recommendations for the nutrition of patients undergoing intensive care.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Designated dietitian for the ward

This is a randomized cluster trial. The centers randomized into this arm will designate a dietitian who will help the ward implement current recommendations for the nutrition of patients undergoing intensive care.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The patient must be insured or beneficiary of a health insurance plan
* Patients hospitalized in intensive care for an expected period greater than 72 hours, and for whom sufficient eating after 72 hours of hospitalization is deemed unlikely upon admission.
* Patients receiving mechanical ventilation and having at least one organ failure other than respiratory failure, defined by a SOFA score greater than 2.

Exclusion Criteria

* The patient is under judicial protection
* The patient (or his/her legal representative or "trusted-person") indicates they do not wish to participate in the study
* It is impossible to correctly inform either the patient or his/her "trusted person"
* The patient is participating in another study, or is in an exclusion period determined by another study
* Moribund patients or those for whom death appears imminent (within 24 hours)
* Survival to Day 28 unlikely due to uncontrollable comorbidities
* Patients with advanced directives issued expressing the wish to not be resuscitated
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire de Nīmes

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Saber Davide Barbar, MD

Role: PRINCIPAL_INVESTIGATOR

Centre Hospitalier Universitaire de Nîmes

Jean-Yves Lefrant, MD, PhD

Role: STUDY_DIRECTOR

Centre Hospitalier Universitaire de Nîmes

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2012-A00626-37

Identifier Type: OTHER

Identifier Source: secondary_id

PHRC-I/2012/SB-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Energy Balance Weight Regulation Study
NCT00619008 COMPLETED PHASE2
The Energy Balance Study
NCT01746186 COMPLETED